Lannett Company Inc. recalls
7 notices naming Lannett Company Inc. as the recalling firm, since December 11, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Lannett Company Inc.: Dextroamphetamine Saccharate
Hazard (FDA): Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
FDAMedicines
Dissolution
Lannett Company Inc.: Niacin Extended-release Tablets
Hazard (FDA): Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
FDAMedicines
Contamination
Lannett Company Inc.: Primidone Tablets USP
Hazard (FDA): Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
FDAMedicines
Dissolution
Lannett Company Inc.: Niacin Extended-release Tablets
Hazard (FDA): Failed Dissolution Specifications
FDAMedicines
Lannett Company Inc.: Dextroamphetamine Saccharate
Hazard (FDA): Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained one (1) tablet of…
FDAMedicines
Lannett Company Inc.: Lisdexamfetamine Dimesylate Capsules
Hazard (FDA): Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
FDAMedicines
Lannett Company Inc.: Lisdexamfetamine Dimesylate Capsules
Hazard (FDA): Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
FDAMedicines